Related references
Note: Only part of the references are listed.AmpliconDesign - an interactive web server for the design of high-throughput targeted DNA methylation assays
Maximilian Schonung et al.
EPIGENETICS (2021)
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
E. A. Klein et al.
ANNALS OF ONCOLOGY (2021)
A DNA methylation-based liquid biopsy for triple-negative breast cancer
Katrina Cristall et al.
NPJ PRECISION ONCOLOGY (2021)
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia
Maximilian Schoenung et al.
CLINICAL CANCER RESEARCH (2021)
Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
J. Moss et al.
ANNALS OF ONCOLOGY (2020)
Machine learning workflows to estimate class probabilities for precision cancer diagnostics on DNA methylation microarray data
Mate E. Maros et al.
NATURE PROTOCOLS (2020)
ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes
Matteo Cassandri et al.
ONCOGENE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
RNA-seq analysis identified hormone-related genes associated with prognosis of triple negative breast cancer
Fei Chen et al.
JOURNAL OF BIOMEDICAL RESEARCH (2020)
Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer
Yanqiu Tong et al.
CANCER CELL INTERNATIONAL (2019)
Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives
Alexander S. Tanas et al.
EPIGENOMICS (2019)
A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
Begona Pineda et al.
CLINICAL EPIGENETICS (2019)
Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer
Justo L. Bermejo et al.
EPIGENOMICS (2019)
Applications of liquid biopsies for cancer
Austin K. Mattox et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol et al.
CANCER CELL (2019)
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Warwick J. Locke et al.
FRONTIERS IN GENETICS (2019)
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer
Jiande Wu et al.
CANCERS (2019)
Long noncoding RNA MIAT regulates apoptosis and the apoptotic response to chemotherapeutic agents in breast cancer cell lines
Zainab A. Almnaseer et al.
BIOSCIENCE REPORTS (2018)
Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry
Cameron M. Scott et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
Mao Shang et al.
JOURNAL OF CANCER (2018)
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Accumulated promoter methylation as a potential biomarker for esophageal cancer
Xianzhen Peng et al.
ONCOTARGET (2017)
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
Martin Widschwendter et al.
GENOME MEDICINE (2017)
Role of Platinum in Early-Stage Triple-Negative Breast Cancer
Alyssa La Belle et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
Maja Olsson et al.
EPIGENETICS (2016)
Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
Magdalena L. Plasilova et al.
MEDICINE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
Iben Daugaard et al.
SCIENTIFIC REPORTS (2016)
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
Natsue Uehiro et al.
BREAST CANCER RESEARCH (2016)
Correlation of an epigenetic mitotic clock with cancer risk
Zhen Yang et al.
GENOME BIOLOGY (2016)
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Clare Stirzaker et al.
NATURE COMMUNICATIONS (2015)
Systematic pan-cancer analysis of tumour purity
Dvir Aran et al.
NATURE COMMUNICATIONS (2015)
Whole genome DNA methylation signature of HER2-positive breast cancer
Breezy M. Lindqvist et al.
EPIGENETICS (2014)
Dysregulation of the epigenome in triple-negative breast cancers: Basal-like and claudin-low breast cancers express aberrant DNA hypermethylation
J. Devon Roll et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
DNA methylation arrays as surrogate measures of cell mixture distribution
Eugene Andres Houseman et al.
BMC BIOINFORMATICS (2012)
19p13.1 Is a Triple-Negative-Specific Breast Cancer Susceptibility Locus
Kristen N. Stevens et al.
CANCER RESEARCH (2012)
Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels
Zhen-Qiang Lian et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
Jo Anders Ronneberg et al.
MOLECULAR ONCOLOGY (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Identification of 5 novel genes methylated in breast and other epithelial cancers
Victoria K. Hill et al.
MOLECULAR CANCER (2010)
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis
Juergen Veeck et al.
CARCINOGENESIS (2008)
Share Paper
